rolabex tablet
bexter (ay) laboratories - brihat bat chintamani - tablet
selabex capsule
bexter (ay) laboratories - sotamul - capsule
klabex powder for suspension
opsonin pharma limited - clarithromycin - powder for suspension - 250 mg/5 ml
klabex tablet
opsonin pharma limited - clarithromycin - tablet - 250 mg
klabex powder for suspension
opsonin pharma limited - clarithromycin - powder for suspension - 125 mg/5 ml
klabex tablet
opsonin pharma limited - clarithromycin - tablet - 500 mg
klabex sr 500 er tablet
opsonin pharma limited - clarithromycin - er tablet - 500 mg
labetalol hydrochloride injection usp solution
jamp pharma corporation - labetalol hydrochloride - solution - 5mg - labetalol hydrochloride 5mg
labetalol hcl tablet, film coated
mckesson corporation dba sky packaging - labetalol hydrochloride (unii: 1gev3baw9j) (labetalol - unii:r5h8897n95) - labetalol hydrochloride 200 mg - labetalol hydrochloride tablets, usp are indicated in the management of hypertension. labetalol hydrochloride tablets, usp may be used alone or in combination with other antihypertensive agents, especially thiazide and loop diuretics. labetalol hydrochloride is contraindicated in bronchial asthma, overt cardiac failure, greater-than-first-degree heart block, cardiogenic shock, severe bradycardia, other conditions associated with severe and prolonged hypotension, and in patients with a history of hypersensitivity to any component of the product [see warnings] . beta-blockers, even those with apparent cardioselectivity, should not be used in patients with a history of obstructive airway disease, including asthma.
labetalol hydrochloride tablet, film coated
ncs healthcare of ky, inc dba vangard labs - labetalol hydrochloride (unii: 1gev3baw9j) (labetalol - unii:r5h8897n95) - labetalol hydrochloride 100 mg - labetalol hcl tablets are indicated in the management of hypertension. labetalol hcl tablets may be used alone or in combination with other antihypertensive agents, especially thiazide and loop diuretics. labetalol hcl tablets are contraindicated in bronchial asthma, overt cardiac failure, greater-than-first-degree heart block, cardiogenic shock, severe bradycardia, other conditions associated with severe and prolonged hypotension, and in patients with a history of hypersensitivity to any component of the product (see warnings ). beta-blockers, even those with apparent cardioselectivity, should not be used in patients with a history of obstructive airway disease, including asthma.